MiNK Therapeutics, Inc. Shares Outstanding (Cover Page)
MiNK Therapeutics, Inc. (INKT) had Shares Outstanding (Cover Page) of 5.10 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 5.10M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 4.98M shares.
- 2026-03-27: Entity Common Stock, Shares Outstanding 4.97M shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 4.69M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 5.10M shares 10-Q · filed 2026-08-13 |
| 2026-05-13 | 4.98M shares 10-Q · filed 2026-05-15 |
| 2026-03-27 | 4.97M shares 10-K · filed 2026-03-31 |
| 2025-11-13 | 4.69M shares 10-Q · filed 2025-11-14 |
| 2025-08-12 | 4.52M shares 10-Q · filed 2025-08-14 |
| 2025-05-12 | 3.99M shares 10-Q · filed 2025-05-15 |
| 2025-03-13 | 3.97M shares 10-K · filed 2025-03-18 |
| 2024-11-08 | 39.55M shares 10-Q · filed 2024-11-14 |
| 2024-08-09 | 39.54M shares 10-Q · filed 2024-08-13 |
| 2024-05-10 | 34.73M shares 10-Q · filed 2024-05-14 |
| 2024-03-15 | 34.70M shares 10-K · filed 2024-03-21 |
| 2023-11-03 | 34.52M shares 10-Q · filed 2023-11-14 |
| 2023-08-04 | 34.51M shares 10-Q · filed 2023-08-10 |
| 2023-05-05 | 34.42M shares 10-Q · filed 2023-05-11 |
| 2023-03-15 | 33.91M shares 10-K · filed 2023-03-24 |
| 2022-10-31 | 33.79M shares 10-Q · filed 2022-11-03 |
| 2022-08-05 | 33.78M shares 10-Q · filed 2022-08-15 |
| 2022-05-06 | 33.56M shares 10-Q · filed 2022-05-13 |
| 2022-02-28 | 33.56M shares 10-K · filed 2022-03-18 |
| 2021-11-26 | 33.50M shares 10-Q · filed 2021-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |